Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma

Liver International

Volumn 34, Issue 7, 2014, Pages 1008-1017

  Kim, Seung Up ^a   Jung, Kyu Sik ^a   Lee, Sarah ^a   Park, Jun Yong ^a   Kim, Do Young ^a   Ahn, Sang Hoon ^a,b   Choi, Gi Hong ^a   Kim, Kyung Sik ^a   Choi, Jin Sub ^a   Han, Kwang Hyub ^a,b   Park, Young Nyun ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Brain Korea 21 PLUS Project of Medical Science   (South Korea)

Author keywords

Chronic hepatitis B; Cirrhosis; Fibrosis; Hepatitis B virus; Hepatocellular carcinoma; Laennec staging; Recurrence; Resection

Indexed keywords

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CLASSIFICATION; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER RESECTION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NONPARAMETRIC TEST; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 84904514723     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12475     Document Type: Article

References (33)

1. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.
2. Yuen MF, Cheng CC, Lauder IJ, et al. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000; 31: 330-5.
3. Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.Ann Surg 2000; 232: 10-24.
4. Poon RT, Fan ST, Ng IO, et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000; 89: 500-7.
5. Shirabe K, Kanematsu T, Matsumata T, et al. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology 1991; 14: 802-5.
6. Garcia-Tsao G, Friedman S, Iredale J, Pinzani M. Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis. Hepatology 2010; 51: 1445-9.
7. Jung KS, Kim SU, Ahn SH, et al. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 2011; 53: 885-94.
8. Wanless IR, Sweeney G, Dhillon AP, et al. Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia. Blood 2002; 100: 1566-9.
9. Kim MY, Cho MY, Baik SK, et al. Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension. J Hepatol 2011; 55: 1004-9.
10. Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 2010; 30: 61-74.
11. Lang BH, Poon RT, Fan ST, Wong J. Perioperative and long-term outcome of major hepatic resection for small solitary hepatocellular carcinoma in patients with cirrhosis. Arch Surg 2003; 138: 1207-13.
12. Stephen BE DR CC, April GF, Frederick LG, Andy T. AJCC cancer staging handbook. New York: Springer-Verlag, 2010: 237-45.
13. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-93.
14. Shimada K, Sakamoto Y, Esaki M, et al. Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 2007; 14: 2337-47.
15. Wei AC, Tung-Ping Poon R, Fan ST, Wong J. Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg 2003; 90: 33-41.
16. Anderson JR, Cain KC, Gelber RD. Analysis of survival by tumor response. J Clin Oncol 1983; 1: 710-9.
17. Ferrell L. Liver pathology: cirrhosis, hepatitis, and primary liver tumors. Update and diagnostic problems. Mod Pathol 2000; 13: 679-704.
18. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
19. Batts KP, Ludwig J. Chronic hepatitis. an update on terminology and reporting. Am J Surg Pathol 1995; 19: 1409-17.
20. Kim BK, Kim do Y, Han KH, et al. Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model. Am J Gastroenterol 2011; 106: 1654-62.
21. Kumar M, Sakhuja P, Kumar A, et al. Histological subclassification of cirrhosis based on histological-haemodynamic correlation. Aliment Pharmacol Ther 2008; 27: 771-9.
22. Nagula S, Jain D, Groszmann RJ, Garcia-Tsao G. Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis. J Hepatol 2006; 44: 111-7.
23. Kim SU, Oh HJ, Wanless IR, et al. The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis. J Hepatol 2012; 57: 556-63.
24. Lee KS, Kim DJ. Management of chronic hepatitis B. Korean J Hepatol 2007; 13: 447-88.
25. Chang WT, Kao WY, Chau GY, et al. Hepatic resection can provide long-term survival of patients with non-early-stage hepatocellular carcinoma: extending the indication for resection? Surgery 2012; 152: 809-20.
26. Lun-Xiu Qin Z-YT. Metastasis and recurrence after surgical resection of hepatocellular carcinoma: recent progress in clinical and related basic aspects. Curr Cancer Ther Rev 2005; 1: 71-80.
27. Wu SD, Ma YS, Fang Y, et al. Role of the microenvironment in hepatocellular carcinoma development and progression. Cancer Treat Rev 2012; 38: 218-25.
28. Villanueva A, Hoshida Y, Battiston C, et al. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology 2011; 140: 1501-12. e2.
29. Revill K, Wang T, Lachenmayer A, et al. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma. Gastroenterology 2013; 5: 01275-4.
30. Hoshida Y, Villanueva A, Kobayashi M, et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 2008; 359: 1995-2004.
31. Wu JC, Huang YH, Chau GY, et al. Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma. J Hepatol 2009; 51: 890-7.
32. Lim KC, Chow PK, Allen JC, et al. Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria. Ann Surg 2011; 254: 108-13.
33. Kim SU, Kim YC, Choi JS, et al. Can preoperative diffusion-weighted MRI predict postoperative hepatic insufficiency after curative resection of HBV-related hepatocellular carcinoma? A pilot study. Magn Reson Imaging 2010; 28: 802-11.